Viewing Study NCT01768195


Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2026-01-19 @ 11:10 PM
Study NCT ID: NCT01768195
Status: UNKNOWN
Last Update Posted: 2017-01-10
First Post: 2013-01-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Sponsor: Peking University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Hepatitis B Virus View
None Therapeutic Uses View
None Antiviral Agents View
None rituximab View